Apocrine encapsulated papillary carcinoma: a comprehensive clinicopathological analysis of 28 cases
Histopathology · 2026-04 · 88 (5) · 1075-1083
DOI: 10.1111/his.70074 ↗Kurz gefasst
Fachartikel in der Zeitschrift Histopathology, online erschienen am 15.12.2025. Verfasst von Ke Zuo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China. Hauptthemen laut MEDLINE: Carcinoma, Papillary, Apocrine Glands, Sweat Gland Neoplasms, Breast Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Aims
Encapsulated papillary carcinoma (EPC) is characterized by neoplastic epithelial cells of low‐to‐intermediate nuclear grade arranged along fibrovascular cores. Classical EPC typically expresses oestrogen receptor (ER) and usually progesterone receptor (PR), while lacking human epidermal growth factor receptor 2 (HER2) overexpression and gene amplification. In contrast, apocrine encapsulated papillary carcinoma (AEPC), an exceptionally rare tumour with only a few well‐characterized cases, exhibits a triple‐negative phenotype (ER‐, PR‐, HER2‐). The purpose of this study is to investigate whether the clinicopathological characteristics of AEPC differ from those of classical EPC.
Methods
Since 2014, 28 cases of AEPC have been identified at the Department of Pathology, Fudan University Shanghai Cancer Centre. We conducted a comprehensive clinicopathological evaluation and prognostic assessment in this case series.
Results
All 28 patients in our study were female, with a median age at diagnosis of 61.5 years (range: 34–90). Fifteen cases were consultation referrals, while 13 cases were diagnosed and treated at our centre. Histologically, all AEPC cases demonstrated cystic architecture with papillary growth patterns. The papillary structures were lined by cells exhibiting uniform apocrine differentiation. The degree of cellular atypia ranged from mild‐to‐moderate, with no severe atypia identified. Notably, myoepithelial cells were absent in both the papillary structures and lesion peripheries. Among the 28 AEPC cases, 18 were non‐invasive, 8 demonstrated microinvasion (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
ORCID-Profile: Ke Zuo, Ruohong Shui, Xiaoli Xu, Baohua Yu, Xiaoyu Tu, Yufan Cheng, Shaoxian Tang, Xiangjie Sun, Rui Bi, Wentao Yang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zuo, K., Shui, R., Xu, X., Yu, B., Tu, X., Cheng, Y., Tang, S., Sun, X., Bi, R., & Yang, W. (2026). Apocrine encapsulated papillary carcinoma: a comprehensive clinicopathological analysis of 28 cases. Histopathology, 88(5), 1075-1083. https://doi.org/10.1111/his.70074
Vancouver
Zuo K, Shui R, Xu X, Yu B, Tu X, Cheng Y, et al. Apocrine encapsulated papillary carcinoma: a comprehensive clinicopathological analysis of 28 cases. Histopathology. 2026;88(5):1075-1083. doi:10.1111/his.70074
BibTeX
@article{Zuo2026,
author = {Zuo, Ke and Shui, Ruohong and Xu, Xiaoli and Yu, Baohua and Tu, Xiaoyu and Cheng, Yufan and Tang, Shaoxian and Sun, Xiangjie and Bi, Rui and Yang, Wentao},
title = {Apocrine encapsulated papillary carcinoma: a comprehensive clinicopathological analysis of 28 cases},
journal = {Histopathology},
year = {2026},
volume = {88},
number = {5},
pages = {1075--1083},
doi = {10.1111/his.70074}
}
EUVIMED